(Q50776665)

19 March 2018

title

Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. (English)

1 reference

19 March 2018

author

Vesa Kataja

7

1 reference

19 March 2018

author name string

Anna Sutela

1

1 reference

19 March 2018

Ritva Vanninen

2

1 reference

19 March 2018

Mazen Sudah

3

1 reference

19 March 2018

Marja Berg

4

1 reference

19 March 2018

Vesa Kiviniemi

5

1 reference

19 March 2018

Jaana Rummukainen

6

1 reference

19 March 2018

Vesa Kärjä

8

1 reference

19 March 2018

publication date

1 January 2008

1 reference

19 March 2018

published in

Acta Oncologica

1 reference

19 March 2018

volume

47

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

38-46

1 reference

19 March 2018

Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Preoperative assessment of prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Current and future status of adjuvant therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Stereotactic core biopsy of breast microcalcifications: comparison of film versus digital mammography, both using an add-on unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

Current perspectives on HER2 testing: a review of national testing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860701441822

10.1080/02841860701441822

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018